BIIB

Key Statistics

Recent News

• Biogen (BIIB) Reports Q2: Everything You Need To Know Ahead Of Earnings Yahoo

  Biotech company Biogen (NASDAQ:BIIB) will be reporting results this Wednesday before market hours. Here’s what to look for.

• The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals Yahoo

  HRMY, ACAD, BIIB, INSM and AGIO are set to report Q2 results, with positive Earnings ESPs suggesting potential earnings surprises.

• Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss? Yahoo

  Harmony Biosciences, Acadia, Biogen, Insmed and Agios show positive Earnings ESPs ahead of Q2 results, setting up closely watched earnings reports.

• A Deeper Dive Into Design Therapeutics SeekingAlpha

  Design Therapeutics' DT-216P2 showed 6.4-point mFARS gains in Friedreich’s ataxia, but data is early. Click here to read the latest analysis on DSGN stock.

• Biogen Q2 Earnings: Can New Drugs Counter Falling MS Sales? Yahoo

  BIIB heads into Q2 results with new launches expected to offset weaker MS drug sales as investors watch Leqembi trends and the Apellis deal impact.

• Will PTC Therapeutics (PTCT) Report Negative Earnings Next Week? What You Should Know Yahoo

  PTC Therapeutics (PTCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

• Analysts Estimate Biogen Inc. (BIIB) to Report a Decline in Earnings: What to Look Out for Yahoo

  Biogen (BIIB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

• Biogen And The Limitation Of The Tau Approach To Alzheimer's Disease SeekingAlpha

  Biogen’s (BIIB) FDA-approved injectable Leqembi cuts infusion costs but risks brain bleeds; see how diranersen compares and why neither may boost valuation.